Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 367,024 | 17,485 | -25,091 | -58,573 | -17,914 |
| Depreciation Amortization | 1,265 | 1,519 | 759 | 935 | 1,449 |
| Income taxes - deferred | -245,852 | N/A | N/A | N/A | N/A |
| Accounts receivable | -10,148 | -11,065 | 9,770 | -24,848 | 501 |
| Accounts payable and accrued liabilities | 3,852 | -3,803 | -366 | 3,788 | 41 |
| Other Working Capital | -19,512 | 153 | 9,517 | -29,049 | 9,718 |
| Other Operating Activity | -20,974 | 27,182 | -332 | 33,989 | 12,083 |
| Operating Cash Flow | $75,655 | $31,471 | $-5,743 | $-73,758 | $5,878 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -92,365 | 4,428 | 10,444 | 72,334 | -79,409 |
| PPE Investments | N/A | 62 | 259 | 443 | -627 |
| Purchase Sale Intangibles | N/A | -360 | -15,000 | N/A | N/A |
| Other Investing Activity | 0 | -360 | -15,000 | 0 | 0 |
| Investing Cash Flow | $-92,365 | $4,130 | $-4,297 | $72,777 | $-80,036 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 19,542 | N/A |
| Debt Repayment | -7,500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,101 | 1,964 | 1,049 | 2,124 | 4,775 |
| Other Financing Activity | 0 | -13,605 | 17,318 | -15,116 | 57,900 |
| Financing Cash Flow | $601 | $-11,641 | $18,367 | $6,550 | $62,675 |
| Beginning Cash Position | 56,746 | 32,786 | 24,459 | 18,890 | 30,373 |
| End Cash Position | 40,637 | 56,746 | 32,786 | 24,459 | 18,890 |
| Net Cash Flow | $-16,109 | $23,960 | $8,327 | $5,569 | $-11,483 |
| Free Cash Flow | |||||
| Operating Cash Flow | 75,655 | 31,471 | -5,743 | -73,758 | 5,878 |
| Capital Expenditure | N/A | -36 | N/A | -450 | -627 |
| Free Cash Flow | 75,655 | 31,435 | -5,743 | -74,208 | 5,251 |